Kimberly Hoang, MD
Neurological Surgery · Houston, TXNPI 1093071029
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. GT Medical Technologies, Inc accounts for 67.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $3,350 and has fallen 95.7% since, to $146 in 2025.
Across 24 payments — averaging $265.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$4K
- Medtronic$781
- Novocure Inc.$610
- Monteris Medical Corporation$298
- Spineology Inc.$218
- Alphatec Spine, Inc$140
- plus $49 from 2 others
Across 51 payments — averaging $2645.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GT Medical Technologies, Inc$103K
- Verastem, Inc.$19K
- NX Development Corp.$13K
What the payments were for
- Consulting fees$2,50039%
- Speaking & faculty fees$75012%
- Travel & lodging$1,15118%
- Food & beverage$1,97031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 8 | $4,275 |
| Medtronic | 6 | $781 |
| Novocure Inc. | 4 | $610 |
| Monteris Medical Corporation | 2 | $298 |
| Spineology Inc. | 1 | $218 |
| Alphatec Spine, Inc | 1 | $140 |
| Stryker | 1 | $38 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GammaTile$4,070
- VISUALASE$570
- Optune$464
- Neuroblate$298
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$218
- Optune Gio$146
- INVICTUS OPEN$140
How this compares
$6,371 in reported general payments places this provider in the 60th percentile of 582 neurological surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 32 | $327 |
| Dexamethasone | 17 | $282 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $111 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Houston
- Andrew RoeserHouston$660K
- Paul HolmanHouston$516K
- Taylor GistHouston$447K
- Meng HuangHouston$324K
- Laurence RhinesHouston$322K
- Omar TanweerHouston$254K
- Jeremy WangHouston$231K
- Alexander RopperHouston$208K
- Fangyi ZhangHouston$192K
- Ashwin ViswanathanHouston$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.